Qyuns Therapeutics Co Ltd (2509.HK)
HKD 7.76
(-3.72%)
HKD 7.76
(-3.72%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -342.95 Million | -275.22 Million | -157.6 Million |
| Net Income | -561.06 Million | -346.75 Million | -359.48 Million |
| Depreciation & Amortization | 35.67 Million | 35.51 Million | 30.9 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 131.29 Million | 41.55 Million | 11.73 Million |
| Change in working capital | 55.23 Million | 31.23 Million | 23.57 Million |
| Other non-cash items | 124.32 Million | 60.9 Million | 188.26 Million |
| Investing Cash Flow | 263.47 Million | -11.19 Million | -306.69 Million |
| Investments in PPE | -8.78 Million | -26.47 Million | -71.03 Million |
| Acquisitions | - | - | - |
| Investment purchases | -872.94 Million | -2.44 Billion | -964.16 Million |
| Sales/Maturities of investments | 1.14 Billion | 2.45 Billion | 728.5 Million |
| Other Investing Activities | 250.98 Million | -48.84 Thousand | -189.44 Million |
| Financing Cash Flow | 83.5 Million | 263.83 Million | 357.62 Million |
| Debt repayment | -53.81 Million | -1.04 Million | -361.65 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 31.69 Million | 264.71 Million | -310.94 Thousand |
| Other Financing Activities | 14.25 Million | 212.14 Million | 284.48 Million |
| Accounts receivables | - | - | - |
| Accounts payables | 79.67 Million | 14.89 Million | 20.94 Million |
| Inventory | -5.45 Million | - | - |
| Other working capital | -18.98 Million | 16.34 Million | 2.63 Million |
| Cash at beginning of period | 239.24 Million | 266.73 Million | 309.28 Million |
| Cash at end of period | 238.14 Million | 239.24 Million | 266.73 Million |
| Capital Expenditure | -8.78 Million | -26.47 Million | -71.03 Million |
| Effect of forex changes on cash | -426 Thousand | 14.45 Million | -2.72 Million |
| Net cash flow / Change in cash | -1.09 Million | -27.49 Million | -42.54 Million |
| Free Cash Flow | -351.74 Million | -301.7 Million | -228.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -86.05 Million | -86.05 Million | -135.77 Million | -561.06 Million | - | -129.03 Million |
| Depreciation & Amortization | 8.16 Million | 8.16 Million | 8.19 Million | 35.67 Million | - | 8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 25.31 Million | 25.31 Million | 31.8 Million | 131.29 Million | - | 43.15 Million |
| Change in working capital | - | - | 44.23 Million | 55.23 Million | - | - |
| Other non-cash items | 19.15 Million | 19.15 Million | 3.74 Million | 124.32 Million | - | -6.31 Million |
| Investing Cash Flow | 1.69 Million | 1.69 Million | -9.59 Million | 263.47 Million | 101.07 Million | 75.81 Million |
| Investments in PPE | -533.5 Thousand | -533.5 Thousand | -1.56 Million | -8.78 Million | -1.28 Million | -2.55 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -160 Million | -872.94 Million | -130 Million | - |
| Sales/Maturities of investments | - | - | 151.08 Million | 1.14 Billion | 231.57 Million | - |
| Other Investing Activities | 2.22 Million | 2.22 Million | -8.1 Million | 250.98 Million | - | 78.36 Million |
| Financing Cash Flow | 157.22 Million | 157.22 Million | 17.14 Million | 83.5 Million | 47.7 Million | -1.82 Million |
| Debt repayment | - | - | -21.4 Million | -53.81 Million | -51.8 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 31.69 Million | - | - |
| Other Financing Activities | 157.22 Million | 157.22 Million | -3.81 Million | 14.25 Million | - | -1.82 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | 79.67 Million | - | - |
| Inventory | - | - | 2.27 Million | -5.45 Million | - | - |
| Other working capital | - | - | 6.61 Million | -18.98 Million | - | - |
| Cash at beginning of period | - | 216.3 Million | 257.63 Million | 239.24 Million | 192.85 Million | 202.97 Million |
| Cash at end of period | 126.06 Million | 342.36 Million | 216.3 Million | 238.14 Million | 257.63 Million | 192.85 Million |
| Capital Expenditure | -533.5 Thousand | -533.5 Thousand | -1.56 Million | -8.78 Million | -1.28 Million | -2.55 Million |
| Effect of forex changes on cash | 571 Thousand | 571 Thousand | -360 Thousand | -426 Thousand | -213 Thousand | 73.5 Thousand |
| Net cash flow / Change in cash | 126.06 Million | 126.06 Million | -41.33 Million | -1.09 Million | 64.77 Million | -10.11 Million |
| Free Cash Flow | -33.95 Million | -33.95 Million | -50.08 Million | -351.74 Million | -85.06 Million | -86.73 Million |
1796
SPHRF
PEG
MITPF
PNSE
ORLCF